Pure Global

Everolimus Eluting Coronary Stent Evermine50™ - ARCSA Registration 57fd6da0c2129d87ae969d2050ecc8cb

Access comprehensive regulatory information for Everolimus Eluting Coronary Stent Evermine50™ in the Ecuador medical device market through Pure Global AI's free database. This IV medical device is registered under ARCSA ID 57fd6da0c2129d87ae969d2050ecc8cb and manufactured by MERIL LIFE SCIENCES PVT. LTD.. The device was registered on August 30, 2020.

This page provides complete registration details including product type (Invasive), manufacturer information, authorized representative details, and regulatory compliance data from the official Ecuador ARCSA medical device database. Pure Global AI offers free access to Ecuador's complete medical device registry.

Free Database
Powered by Pure Global AI
ARCSA Official Data
IV
57fd6da0c2129d87ae969d2050ecc8cb
Everolimus Eluting Coronary Stent Evermine50™
ARCSA ID: 57fd6da0c2129d87ae969d2050ecc8cb
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing
Device Classification
Risk Class
IV
Product Type
Invasive
Brand Name
CRITERIA
Commercial Name
Stents, Vascular, Coronary, Balloon Expandable, Drug Elution
Registration Information
Analysis ID
57fd6da0c2129d87ae969d2050ecc8cb
Registration Date
August 30, 2020
Expiration Date
August 30, 2025
Product Use

THE EVERMINE 50 EVEROLIMUS ELUTING CORONARY STENT SYSTEM IS INDICATED TO IMPROVE CORONARY LUMINAL DIAMETER IN PATIENTS WITH SYMPTOMATIC ISCHEMIC HEART DISEASE IN PATIENTS ELIGIBLE FOR STENT PROCEDURES AND PERCUTANEOUS TRANSLUMINAL CORONARY ANGIOPLASTY (PTCA).

Manufacturer
City
VAPI
Country
INDIA
Address
MUKTANAND MARG, CHALA, VAPI - 396 191, GUJARAT,INDIA.
Product Owner
Name
MERIL LIFE SCIENCES PVT. LTD.
Country
INDIA
Authorized Representative
Address
THE SN TELEGRAPH AND LATEST NEWS
Phone
2520070